HIVandHepatitis.com
 Google Custom Search

HCV - Liver / Kidney
Transplantation

Metabolic Syndrome Is a Risk after Liver Transplantation, Leading to Poor Outcomes
1-15-2010

African Americans with Hepatitis C Have Worse Outcomes than White Patients after Liver Transplantation
12/15/09

Hepatitis C Patients Can Have Good Outcomes after Transplants Using HBV+/HCV+ Liver Grafts, but Donor Status May Affect HCV Recurrence
11/20/09

FDA Alert Warns of Elevated Risk of Death in Liver Transplant Recipients Who Switch to Rapamune (Sirolimus)
6/16/09

Kidney Disease in Patients with Chronic Hepatitis C
9/23/08

Older Donor Liver Grafts May Be Suitable for Chronic Hepatitis C Patients Requiring Transplantation
9/05/08

Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation
 6/10/08

Marijuana Use Sparks Liver Transplant Controversy
 6/06/08

FibroScan Liver Stiffness Measurement Distinguishes Fast and Slow Fibrosis Patterns after Liver Transplantation
 5/16/08

Prophylaxis with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin vs No Prophylaxis after Liver Transplantation - 11/27/07

Sodium Levels Can Help Predict Outcomes before and after Liver Transplantation   - 8/07/07

Treatment of Recurrent Hepatitis C in Liver Transplant Recipients     - 7/10/07

Response to PegIntron/ribavirin Leads to Stabilization of Fibrosis in Liver Transplant Recipients  - 5/01/07

Pegylated Interferon/ribavirin Therapy Results in Low SVR Rates after Liver Transplantation in HIV-HCV Coinfected Patients  - 3/27/07

Sustained Virological Response Improves Fibrosis Progression and Reduces Mortality after Liver Transplantation   2/23/07